ArticleInternational journal of molecular medicine2019

TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.

Dan-Hong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.